July 2018—SpeeDx’s ResistancePlus MG Positive Control kit has been cleared by the FDA. The kit contains synthetic DNA to simulate Mycoplasma genitalium as well as five mutations known to confer resistance to macrolide antibiotics.
SpeeDx, 512-200-6918
Tagged with: SpeeDx